
Artificial intelligence has identified two plant-derived bioactive compounds that may activate the glucagon-like-peptide-1 receptor (GLP-1R), a target for existing weight loss drugs, potentially offering natural alternatives with fewer side effects and oral administration.


coremsg

Two bioactive, natural-derived compounds, which show activity at the GLP-1R site, may be orally administered with fewer side effects than their pharmaceutical counterparts.

AI Identifies Two Natural Bioactive GLP-1 Compounds

ai-identifies-two-natural-plant-derived-compounds-with-potential-as-weight-loss-drugs-targeting-glp-1-receptor


AI Identifies Two Natural Plant-Derived Compounds with Potential as Weight Loss Drugs Targeting GLP-1 Receptor
